Bulletin of the Korean Chemical Society

Korean Chemical Society (대한화학회)
권호 표지
DOI QR코드

DOI QR Code

Mechanistic Insights into in vitro DNA Adduction of Oxaliplatin

  • Kim, Yea-Seul (Department of Chemistry and Research Institute for Basic Sciences, Kyung Hee University) ;
  • Shin, Seon-Mi (Department of Chemistry and Research Institute for Basic Sciences, Kyung Hee University) ;
  • Cheong, Min-Serk (Department of Chemistry and Research Institute for Basic Sciences, Kyung Hee University) ;
  • Hah, Sang-Soo (Department of Chemistry and Research Institute for Basic Sciences, Kyung Hee University)
  • Received : 2010.04.27
  • Accepted : 2010.05.03
  • Published : 2010.07.20
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Saunders, M.; Iveson, T. Br. J. Cancer 2006, 95, 131-138. https://doi.org/10.1038/sj.bjc.6603233
  2. Graham, J.; Muhsin, M.; Kirkpatrick, P. Nat. Rev. Drug Discov.2004, 3, 11-12. https://doi.org/10.1038/nrd1287
  3. Wang, D.; Lippard, S. J. Nature Rev. Drug Discov. 2005, 4, 307-320. https://doi.org/10.1038/nrd1691
  4. Jamieson, E. R.; Lippard, S. J. Chem. Rev. 1999, 99, 2467-2498. https://doi.org/10.1021/cr980421n
  5. Pendyala, L.; Creaven, P. J. Cancer Res. 1993, 53, 5970-5976.
  6. Di Francesco, A. M.; Ruggiero, A.; Riccardi, R. Cell Mol. Life Sci. 2002, 59, 1914-1927. https://doi.org/10.1007/PL00012514
  7. Hah, S. S.; Stivers, K. M.; de Vere White, R. W.; Henderson,P. T. Chem. Res. Toxicol. 2006, 19, 622-626. https://doi.org/10.1021/tx060058c
  8. Chaney, S. G.; Campbell, S. L.; Bassett, E.; Wu, Y. Crit. Rev. Oncol. Hematol.2005, 53, 3-11. https://doi.org/10.1016/j.critrevonc.2004.08.008
  9. Desoize, B.; Madoulet, C. Crit. Rev. Oncol. Hematol. 2002, 42, 317-325. https://doi.org/10.1016/S1040-8428(01)00219-0
  10. Kartalou, M.; Essigmann, J. M.Mutat. Res. 2001, 478, 1-21. https://doi.org/10.1016/S0027-5107(01)00142-7
  11. Fuertes, M. A.; Alonso, C.; Perez,J. M. Chem. Rev. 2003, 103, 645-662. https://doi.org/10.1021/cr020010d
  12. Oshita, F.; Eastman, A. Oncol. Res. 1993, 5, 111-118.
  13. Summa, N.; Schiessl, W.; Puchta, R.; van Eikema, H. N.; vanEldik, R. Inorg. Chem. 2006, 45, 2948-2959. https://doi.org/10.1021/ic051955r
  14. Jerremalm, E.;Eksborg, S.; Ehrsson, H. J. Pharm. Sci. 2003, 92, 436-438. https://doi.org/10.1002/jps.10306
  15. Jerremalm, E.; Videhult, P.; Alvelius, G.; Griffiths, W. J.; Bergman,T.; Eksborg, S.; Ehrsson, H. J. Pharm. Sci. 2002, 91, 2116-2121. https://doi.org/10.1002/jps.10201
  16. Knox, R. J.; Friedlos, F.; Lydall, D. A.; Roberts, J. J. Cancer Res. 1986, 46, 1972-1979.
  17. Canovese, L.; Cattalini, L.; Chessa,G.; Tobe, M. L. J. Chem. Soc., Dalton Trans. 1988, 8, 2135-2140.
  18. Graham, M. A.; Lockwood, G. F.; Greenslade, D.; Brienza, S.;Bayssas, M.; Gamelin, E. Clin. Cancer Res. 2000, 6, 1205-1218.
  19. Hah, S. S. J. Biomed. Sci. 2009, 16, 54. https://doi.org/10.1186/1423-0127-16-54
  20. Hah, S. S. Anal. Sci. 2009, 25, 731-733. https://doi.org/10.2116/analsci.25.731
  21. Mundt, J. M.; Hah, S. S.; Sumbad, R.A.; Schramm, V.; Henderson, P. T. Nucleic Acids Res. 2008, 36,228-236. https://doi.org/10.1093/nar/gkm1032
  22. Hah, S. S.; Mundt, J. M.; Ubick, E. A.; Turteltaub,K. W.; Gregg, J. P.; Henderson, P. T. Nucl. Instr. Methods Phys. Res. B 2007, 259, 763-766. https://doi.org/10.1016/j.nimb.2007.01.214
  23. Hah, S. S.; Kim, H. M.; Sumbad,R. A.; Henderson, P. T. Bioorg. Med. Chem. Lett. 2005, 15, 3627-3631. https://doi.org/10.1016/j.bmcl.2005.05.113
  24. Hah, S. S.; Sumbad, R. A.; Vere White, R. W.; Turteltaub, K. W.;Henderson, P. T. Chem. Res. Toxicol. 2007, 20, 1745-1751. https://doi.org/10.1021/tx700376a
  25. Jerremalm, E.; Hedeland, M.; Wallin, I.; Bondesson, U.; Ehrsson,H. Pharm. Res. 2004, 21, 891-894. https://doi.org/10.1023/B:PHAM.0000026444.67883.83
  26. Bancroft, D. P.; Lepre, C. A.; Lippard, S. J. J. Am. Chem. Soc. 1990,112, 6860-6871. https://doi.org/10.1021/ja00175a020
  27. Woynarowski, J. M.; Chapman, W. G.; Napier, C.; Herzig, M. C.S.; Juniewicz, P. Mol. Pharmacol. 1998, 54, 770-777.
  28. Page, J. D.; Husain, I.; Sancar, A.; Chaney, S. G. Biochemistry1990, 29, 1016-1024. https://doi.org/10.1021/bi00456a026
  29. Jennerwein, M. M.; Eastman, A.; Khokhar, A. Chem. Biol. Interact.1989, 70, 39-49. https://doi.org/10.1016/0009-2797(89)90061-6

Cited by

  1. Determination of the binding sites for oxaliplatin on insulin using mass spectrometry-based approaches vol.401, pp.5, 2011, https://doi.org/10.1007/s00216-011-5239-1
  2. Synthesis, Characterization and in Vitro Antitumor Activity of Platinum(II) Oxalato Complexes Involving 7-Azaindole Derivatives as Coligands vol.19, pp.8, 2014, https://doi.org/10.3390/molecules190810832
  3. Computational insight into the interaction of oxaliplatin with insulin pp.1756-591X, 2019, https://doi.org/10.1039/C8MT00341F
  4. Biological evaluation of redox stable cisplatin/Cu(II)-DNA adducts as potential anticancer agents vol.69, pp.2, 2010, https://doi.org/10.1080/00958972.2015.1105366
  5. A nanobiosensor for the simple detection of small molecules using non-crosslinking aggregation of gold nanoparticles with G-quadruplexes vol.12, pp.3, 2020, https://doi.org/10.1039/c9ay02150g